Aratana Therapeutics Inc (NASDAQ:PETX)

4.12
Delayed Data
As of Feb 20
 -0.06 / -1.44%
Today’s Change
3.91
Today|||52-Week Range
7.67
-21.67%
Year-to-Date

Today’s Trading

Previous close4.18
Today’s open4.18
Day’s range4.10 - 4.24
Volume125,334
Average volume (3 months)475,119
Market cap$179.7M
Data as of 4:15pm ET, 02/20/2018

Growth & Valuation

Earnings growth (last year)+61.22%
Earnings growth (this year)-6.62%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+5,585.99%
P/E ratioNM
Price/Sales6.57
Price/Book1.69

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...-0.05-0.91%
ARDXArdelyx Inc+0.05+0.86%
FBIOFortress Biotech Inc-0.09-2.56%
NLNKNewLink Genetics Cor...+0.02+0.28%
Data as of 4:00pm ET, 02/20/2018

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$38.6M
Annual profit (last year)-$33.6M
Net profit margin-87.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Operating Officer
Brent A. Standridge
Corporate headquarters
Leawood, Kansas

Forecasts